Successful treatment of fulminant hepatitis C by therapy with alpha interferon and ribavirin.
Yu
Ming-Lung
ML
Hou
Nai-Jen
NJ
Dai
Chia-Yen
CY
Chang
Wen-Yu
WY
Chuang
Wan-Long
WL
D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D008099:Liver / Q000473:pathology; D017114:Liver Failure, Acute / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D007370:Interferon Type I; D011994:Recombinant Proteins; D012254:Ribavirin